Drug ETFs Affected by Elections

November 13, 2006 at 8:30 am by Tom Lydon      Bookmark and Share

Images_17 The democratic Congress may effect pharmaceutical exchange traded funds (ETFs). Shares of big pharmaceutical companies slid as the House was taken over last week.  Pharmaceutical HOLDRs (PPH) was down 3.4% for the week and iShares Dow Jones U.S. Pharmaceuticals (IHE) was down 1.4%.

Most analysts are calm with the fact that real change is unlikely reports Judith Levy at Seeking Alpha.  Nancy Pelosi, expected Speaker of the House, is an advocate of legislation that would allow the government direct negotiation with the drug companies for Medicare. This is more of a threat to the smaller drug companies as well as to those new drugs in the pipeline. The good news is most analysts agree this impact will be brief.

Pphelection

Share this post:
  • E-mail this story to a friend!
  • Yahoo! Buzz
  • Digg
  • del.icio.us
  • Tipd
  • Reddit
  • StumbleUpon
  • Facebook
  • Technorati
  • Google Bookmarks
  • TwitThis


Subscribe to Our Daily E-mail Newsletter

Enter your e-mail address below to sign up for our daily e-mail newsletter, the Daily Market Update. We will never share your e-mail address with third parties.

Subscribe to Our RSS Feed

Click here to subscribe to our RSS feed

blog comments powered by Disqus

Recent TV Appearances


Now Available:

The ETF Trend
Following Playbook

ETF Trends' new book is now available. Click here for details. Or order online from one of these bookstores:
Amazon        Barnes and Noble


iMoney

ETF Trends' book iMoney is available. Click here for details. Or order online from one of these bookstores:
Amazon        Amazon